{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:09:40Z","timestamp":1786990180910,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.hroo.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T12:23:42Z","timestamp":1605011022000},"page":"376-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["AnaLysIs of Both sex and device specific factoRs on outcomes in pAtients with non-ischemic cardiomyopathy (BIO-LIBRA): Design and clinical protocol"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-289X","authenticated-orcid":false,"given":"Valentina","family":"Kutyifa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary W.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McNitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlene","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer Z.","family":"Rosero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marye J.","family":"Gleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne E.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2020.11.002_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2020.11.002_bib2","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jacc.2012.12.014","volume":"61","author":"Epstein","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hroo.2020.11.002_bib3","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1016\/j.hrthm.2018.09.026","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2020.11.002_bib4","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2020.11.002_bib5","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jtcvs.2012.08.032","article-title":"2012 ACCF\/AHA\/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"144","author":"Tracy","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hroo.2020.11.002_bib6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"Epstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2020.11.002_bib7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2020.11.002_bib8","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.117.028829","article-title":"Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure","volume":"136","author":"Elming","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2020.11.002_bib9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jacc.2015.12.046","article-title":"Use of guideline-directed medications for heart failure before cardioverter-defibrillator implantation","volume":"67","author":"Roth","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2020.11.002_bib10","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.amjcard.2011.02.322","article-title":"Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure)","volume":"107","author":"Krantz","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2020.11.002_bib11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2020.11.002_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/jwh.2014.4980","article-title":"Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events","volume":"24","author":"Herz","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.hroo.2020.11.002_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jacc.2010.06.061","article-title":"Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial","volume":"57","author":"Arshad","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2020.11.002_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002013","article-title":"Sex differences in long-term outcomes with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block","volume":"4","author":"Biton","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2020.11.002_bib15","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/ehf2.12914","article-title":"Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy","volume":"7","author":"Wilkoff","year":"2020","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.hroo.2020.11.002_bib16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jacep.2019.06.007","article-title":"Cardiac resynchronization in women: A substudy of the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial","volume":"5","author":"de Waard","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2020.11.002_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/europace\/eux203","article-title":"Do women benefit equally as men from the primary prevention implantable cardioverter-defibrillator?","volume":"20","author":"Barra","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2020.11.002_bib18","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1161\/CIRCULATIONAHA.106.673442","article-title":"Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"115","author":"O'Meara","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2020.11.002_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/europace\/eux094","article-title":"Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis","volume":"20","author":"Barra","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2020.11.002_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jce.12701","article-title":"Sex differences in device therapies for ventricular arrhythmias or death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial","volume":"26","author":"Tompkins","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2020.11.002_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ahj.2015.02.025","article-title":"Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR)","volume":"170","author":"Russo","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.hroo.2020.11.002_bib22","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.hrthm.2015.06.039","article-title":"A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model","volume":"12","author":"Shadman","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2020.11.002_bib23","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2020.11.002_bib24","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/europace\/euz065","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"21","author":"Stiles","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2020.11.002_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.65.3.457","article-title":"Clinical classification of cardiac deaths","volume":"65","author":"Hinkle","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2020.11.002_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacep.2016.09.006","article-title":"Does the implantable cardioverter-defibrillator benefit vary with the estimated proportional risk of sudden death in heart failure patients?","volume":"3","author":"Levy","year":"2017","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266650182030146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266650182030146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:24:03Z","timestamp":1762993443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266650182030146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S266650182030146X"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2020.11.002","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AnaLysIs of Both sex and device specific factoRs on outcomes in pAtients with non-ischemic cardiomyopathy (BIO-LIBRA): Design and clinical protocol","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}